Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 22:27:39 - browse：8

Insitro CEO and founder Daphne Koller Neilson Barnard/Getty Images for The New York Times

SAN FRANCISCO — It took only a single, one-hour meeting in a Starbucks to convince venture capitalist Robert Nelsen that he was going to invest in the company being built by machine-learning whiz Daphne Koller. “She’s just an amazing force of nature,” said Nelsen, who invests for ARCH Venture Partners.

Koller’s company, Insitro, in a matter of months raised over $100 million from big-name investors including ARCH, Foresite Capital, Andreessen Horowitz, and the firm that manages Jeff Bezos’ personal VC investments. (Koller refers to Bezos by his first name.) Now, it’s time for the next step. On Tuesday, the giant drug maker Gilead Sciences said it would pay Insitro $15 million — and up to $1 billion more down the line if it meets certain goals — for help in developing drugs to treat a common liver disease. It is the South San Francisco-based company’s first deal with a drug maker, and offers a test of whether artificial intelligence can remake drug development.

The very nature of the financials emphasize the exciting but risky reality: The technology has great promise, but nothing is guaranteed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Harvard scientists, with Google, unveil the most detailed brain map ever

WSS

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

Drug companies' payments and gifts affect physicians' prescribing

After Sarepta trial failure, Duchenne families brace for more debate

Harvard scientists, with Google, unveil the most detailed brain map ever

Lung cancer screening guidelines updated for cigarette smokers

Trial using CRISPR to edit HIV out of cells disappoints

hotspot

Wikipedia

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Trial using CRISPR to edit HIV out of cells disappoints

BioMarin wins approval for gene therapy to treat hemophilia A

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

Sports medicine is finally prioritizing gender equality

Gene therapy’s promise and the high cost of hope

ChatGPT in medicine: STAT answers readers' burning questions

Multiple sclerosis has subtypes with different best treatments: study

Novavax promises a turnaround & Lilly roils the obesity market

Researchers test human milk's ability to repair gut microbiome

hotspot

Researchers test human milk's ability to repair gut microbiome

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Scientists uncover potential path to treating deadly childhood tumor

The health care issue Democrats can’t solve: hospital reform

Drug companies' payments and gifts affect physicians' prescribing

U.K. decision on ALS drug has neurologists, advocates up in arms

hotspot

hotspot

focus

focus